The Stanford Cancer Institute is an NCI-designated Cancer Center at Stanford University in Palo Alto, CA. It is one of eight comprehensive cancer centers in California.
The Stanford Cancer Institute leverages the scientific, technological, and human resources of Stanford University and Stanford Health Care to enhance the understanding of cancer. It facilitates the translation of research discoveries into improved prevention strategies, diagnostic methods, and more effective and safer therapies.
The Stanford Cancer Institute has more than 300 faculty members within the Stanford network.[1] Adult patients are treated at the Stanford Cancer Center.[2]
The Stanford Cancer Institute was founded in 2004 and first received NCI-designation as a clinical cancer center in 2007. In 2016, it received its comprehensive cancer center designation.[3][1] In 2022, the Stanford Cancer Institute received its comprehensive cancer center designation renewal.
Stanford University was a founding member of the National Comprehensive Cancer Network in 1995.[4]
In 2016, a new center was created as part of the Parker Institute for Cancer Immunotherapy. Stanford received $10 million from the Parker Foundation. This is a $250 million joint venture with five other cancer centers across the country.[5]
In 2017, a donation by Jeffrey Rothschild established the Stanford Center for Cancer Cell Therapy, which supports research into the development of immunological based treatments for cancer.[6]